ACTIVE

BIOXTRACT

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result31,1 k €-87,6 %over 1 year

Gross margin302,3 k €-50,4 %over 1 year

Equity1,1 M €+3,0 %over 1 year

Workforce0,5 ETP-37,5 %over 1 year

Identity

Source · BCE/KBO

BIOXTRACT is a Public limited company incorporated in 2003. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Somme-Leuze. It employs on average 0,5 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0480.174.942
Incorporation: 08/05/2003
Legal form: Public limited company
Registered office: Zone d'activités Nord, Bail. 1 box 2
5377 Somme-Leuze · WallonieSee on map
Contributed capital: 541 636,00 €
Latest accounts: 31/12/2025
Average workforce: 0,5 ETP

Activities (NACE)

72109Research and experimental development on natural sciences and engineering· main 72190Other research and experimental development on natural sciences and engineering 73100Advertising 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 47740Retail sale of medical and orthopaedic goods in specialised stores+3

Joint committees (1)

Contacts

4 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 21 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	302,3 k €	-50.4%	609,9 k €	-2.8%	627,6 k €	+2.9%	609,7 k €	-15.4%	720,5 k €
EBITDA	232,1 k €	-50.0%	464,7 k €	+13.1%	410,9 k €	+35.4%	303,5 k €	-32.0%	446,5 k €
Operating result	204,3 k €	-47.3%	387,9 k €	+32.6%	292,5 k €	+90.8%	153,3 k €	-35.8%	238,9 k €
Net result	31,1 k €	-87.6%	250,8 k €	+11.4%	225,2 k €	+1067%	19,3 k €	-89.6%	186,4 k €
Balance sheet
Equity	1,1 M €	+3.0%	1 M €	+32.4%	772,9 k €	+41.1%	547,6 k €	+3.7%	528,3 k €
Total assets	1,1 M €	-9.7%	1,2 M €	+7.1%	1,1 M €	+43.9%	785 k €	-33.3%	1,2 M €
Cash	457,3 k €	+8.7%	420,5 k €	+145%	171,3 k €	+472%	29,9 k €	-79.6%	147 k €
Debts	37,5 k €	-79.9%	186,6 k €	-47.8%	357,2 k €	+50.5%	237,4 k €	-63.4%	648,8 k €
Other
Workforce	0,5 ETP	-37.5%	0,8 ETP	-46.7%	1,5 ETP	-34.8%	2,3 ETP	-8.0%	2,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 8 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CHRISTIAN DAWIR	Managing director17/06/2019 → 21/11/2029Director23/10/2013 → 17/06/2019ended
JEAN-NOËL TILMAN	Director23/10/2013 → 21/11/2029
YVAN DIERCKXSENS	Director23/10/2013 → 21/11/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ITERO SPRL0823.337.384Represented by RICHARD BRACHWITZ	Director23/10/2013 → 2020 accounts
JEAN CLAUDE JUNGELS	Managing director23/10/2013 → 17/06/2019
PIERRE-HADI SAAD	Director23/10/2013 → 18/12/2020

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/07/2026	30/07/2025	29/08/2024	25/08/2023	26/08/2022	28/06/2021
General meeting	29/06/2026	24/06/2025	18/07/2024	27/06/2023	20/06/2022	21/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/06/2026	31/07/2026	French	PDF
Abridged model	31/12/2024	24/06/2025	30/07/2025	French	PDF
Abridged model	31/12/2023	18/07/2024	29/08/2024	French	PDF
Abridged model	31/12/2022	27/06/2023	25/08/2023	French	PDF
Abridged model	31/12/2021	20/06/2022	26/08/2022	French	PDF
Abridged model	31/12/2020	21/06/2021	28/06/2021	French	PDF
Abridged model	31/12/2019	22/06/2020	28/08/2020	French	PDF
Abridged model	31/12/2018	17/06/2019	23/08/2019	French	PDF
Abridged model	31/12/2017	18/06/2018	19/08/2018	French	PDF
Abridged model	31/12/2016	12/06/2017	18/06/2017	French	PDF
Abridged model	31/12/2015	13/06/2016	22/08/2016	French	PDF
Abridged model	31/12/2014	29/06/2015	21/08/2015	French	PDF
Abridged model	31/12/2013	16/06/2014	18/08/2014	French	PDF
Abridged model	31/12/2012	07/06/2013	22/07/2013	French	PDF
Abridged model	31/12/2011	19/06/2012	16/07/2012	French	PDF
Abridged model	31/12/2010	30/08/2011	31/08/2011	French	PDF
Abridged modelCorrection	31/12/2009	12/05/2010	04/06/2012	French	PDF
Abridged model	31/12/2009	12/05/2010	31/08/2010	French	PDF
Abridged model	31/12/2008	29/04/2009	27/07/2009	French	PDF
Abridged model	31/12/2007	16/04/2008	27/05/2008	French	PDF
Abridged model	31/12/2006	18/04/2007	30/05/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 8 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CHRISTIAN DAWIR	Managing director17/06/2019 → 21/11/2029Director23/10/2013 → 17/06/2019ended
JEAN-NOËL TILMAN	Director23/10/2013 → 21/11/2029
YVAN DIERCKXSENS	Director23/10/2013 → 21/11/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ITERO SPRL0823.337.384Represented by RICHARD BRACHWITZ	Director23/10/2013 → 2020 accounts
JEAN CLAUDE JUNGELS	Managing director23/10/2013 → 17/06/2019
PIERRE-HADI SAAD	Director23/10/2013 → 18/12/2020

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates21/05/2024
DEMISSIONS, NOMINATIONS
PDF
Registered office13/09/2023
SIEGE SOCIAL
PDF
Mandates29/03/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates22/08/2019
DEMISSIONS, NOMINATIONS
PDF
Mandates18/12/2013
DEMISSIONS, NOMINATIONS
PDF
Mandates15/10/2013
DEMISSIONS, NOMINATIONS
PDF
Mandates04/12/2012
DEMISSIONS, NOMINATIONS
PDF
Mandates15/06/2012
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

JEAN-NOËL TILMAN

CHRISTIAN DAWIR

YVAN DIERCKXSENS

ITERO SPRL

PIERRE-HADI SAAD

JEAN CLAUDE JUNGELS

START-IT

CATHERINE PETIT

Roland HUSSON

MARC DUBOIS

FABIAN PRIEM

200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

BIOXTRACT

Zone d'activités Nord, Bail. 1 bte 2, 5377 Somme-LeuzeRue Guillaume Fouquet,Isnes 30, 5032 Mazy

Director

Managing directorDirector

Director

Managing director

Director

DirectorManaging director

DirectorChairman of the board of directors

DirectorManaging director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Zone d'activités Nord, Bail. 1 bte 2, 5377 Somme-LeuzeCurrent	accounts 2023 → 2025	Accounts 2025 · 2026-00366370
Rue Guillaume Fouquet,Isnes 30, 5032 Mazy	accounts 2021 → 2022	Accounts 2022 · 2023-00354138

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
BIOXTRACTCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00366370

Events

2025
Annual accounts 202531,1 k €↓
2024
Annual accounts 2024250,8 k €↑
2023
Annual accounts 2023225,2 k €↑
2022
Annual accounts 202219,3 k €↓
2021
Annual accounts 2021186,4 k €↑
2020
Annual accounts 2020138,3 k €↑
2019
Annual accounts 2019-204,2 k €↓
2018
Annual accounts 201829,5 k €↓
2017
Annual accounts 2017148,4 k €↓
2016
Annual accounts 2016175,8 k €↑
2015
Annual accounts 2015169,2 k €↑
2014
Annual accounts 20149,1 k €↓
2013
Annual accounts 201313 k €↑
2012
Annual accounts 20126,5 k €↓
2011
Annual accounts 201166,7 k €↑
2010
Annual accounts 2010-277,9 k €↑
2009
Annual accounts 2009-386,9 k €↓
2008
Annual accounts 200896,2 k €↑
2007
Annual accounts 200748,7 k €↑
2006
Annual accounts 2006-24,9 k €
08/05/2003
IncorporationPublic limited company

BIOXTRACT

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events